Evidence map›Paper›PMID 42445593›Full record

ArticleJournal of preventive medicine and hygiene2026

Cost-Benefit Analysis of Increasing the Exclusive Breastfeeding Rate in Italy.

Enrico Urpis, Carmen Tereanu

Abstract read
In one paragraph

Article in Journal of preventive medicine and hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Enrico UrpisDepartment of Medical and Surgical Specialities, Radiological Sciences and Public Health, Università di Brescia, Italy.
Carmen TereanuDepartment of Medical and Surgical Specialities, Radiological Sciences and Public Health, Università di Brescia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Exclusive breastfeeding (EBF) is widely regarded as the optimal method for feeding newborns. While existing literature primarily emphasizes the medical benefits, such as enhanced disease resistance and improved health indicators, this paper proposes a conservative cost-saving exercise of exclusive breastfeeding during the first five months of an infant's life. Methods: Based on the EBF rates in Italy for 2019, the last year with data unaffected by the COVID-19 pandemic, we carried-out a conservative cost-saving exercise considering otitis media, gastroenteritis, and respiratory diseases, applying the methodology proposed by Weimer et al. (2001) and Coco (2007). Cost of hospitalization in case of complications or infant death were not included in the analysis. Results: The total savings considering all three simulations combined under different EBF rate scenarios range from a minimum of € 10,5 million (EBF rate of 40%) to a maximum of € 33.7 million (EBF rate of 71%). Moreover, these estimated savings increase when the cost of formula milk is included. Conclusion: Estimates provided in this work are very conservative. Nonetheless, they pointed out important savings due to increasing EBF rates. Policies such as the Baby-Friendly Hospital and the Baby-Friendly Community Initiatives promoted by United Nations International Children's' Emergency Fund and the World Health Organization are valuable tools to improve EBF and we highly recommend their adoption more widely in Italy.

Indexed as

Breast FeedingCost-Benefit AnalysisCost SavingsCOVID-19FemaleGastroenteritisHumansInfantInfant FormulaInfant, NewbornItalyOtitis MediaBreast feedingCostGastroenteritisOtitis mediaRespiratory disease

Identifiers

PMID42445593
PMCPMC13361022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.